EIPCA : Electrocardiogram Interpretation Pattern for Cardiovascular Abnormalities Prediction
Cardiac Arrhythmia is one of the conditions in the group of heart and blood vessel diseases that can lead to sudden cardiac arrest (sudden death) and other conditions if not diagnosed quickly and accurately. According to research, heart and blood vessel diseases are the most common diseases and have a mortality rate of one-half of all non-communicable diseases. According to WHO statistics in 2012, it was found that there were 7.4 million deaths from heart and blood vessel diseases, and in 2017, the number of deaths increased to 177 million people, or about 94,444 people per day. Diagnosis of heart and blood vessel diseases can be done by measuring the electrical activity of the heart, and after the examination, a specialized physician will read and analyze the graph to find abnormal patterns. Currently, the shortage of qualified heart specialists to read the graph and screen for heart disease is a medical position shortage, which requires transferring data to hospitals with specialists, resulting in delays in diagnosis and treatment and even death. The project "EIPCA: Electrocardiogram Interpretation Pattern for Cardiovascular Abnormalities prediction" is an application program that assists in screening for fatal diseases that arise from abnormal heart rhythm. It employs artificial intelligence to aid in the screening and analysis of the electrical waveforms generated by an ECG machine, thus reducing diagnosis time and addressing the shortage of cardiology experts. EIPCA is comprised of two systems: (1) a system for screening and analyzing ECG waveforms using artificial intelligence to solve the problem of a shortage of specialized cardiology physicians, and (2) a system for risk assessment of fatal diseases by analyzing the ECG waveform data. The target group of the project is Rural hospitals, as well as health-related agencies. The project team hopes that the development of this project will significantly improve the efficiency and speed of screening for heart-related diseases, ultimately reducing the mortality rate from these diseases in the future.
Fabrication of Highly Efficient and Cost-effective Tandem Dye-sensitized Solar Cells for Building Integrated Photovoltaics
In recent years, there has been an extreme rise in population and economic development, which requires a great demand for energy worldwide. Global energy consumption has been increasing nearly every year for over half a century [1]; it is rapidly rising in the form of nonrenewable energy, such as coal, oil, natural gas, and fossil fuel. Fossil fuel overreliance has resulted in a dramatic rise in atmospheric carbon dioxide (CO2) concentrations.